These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22943613)

  • 1. Could traditional mass-balance studies in the 'twilight zone' be improved by means of accelerator MS measurements?
    Svensson LD
    Bioanalysis; 2012 Aug; 4(15):1835-7. PubMed ID: 22943613
    [No Abstract]   [Full Text] [Related]  

  • 2. Applications of accelerator MS in pediatric drug evaluation.
    Vuong LT; Blood AB; Vogel JS; Anderson ME; Goldstein B
    Bioanalysis; 2012 Aug; 4(15):1871-82. PubMed ID: 22943618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dating and measurements of radioactive isotopes with accelerator mass spectrometry].
    Nakai N; Nakamura T
    Radioisotopes; 1983 Dec; 32(12):645-55. PubMed ID: 6374773
    [No Abstract]   [Full Text] [Related]  

  • 4. Accelerator mass spectrometry for biomedical research.
    Brown K; Dingley KH; Turteltaub KW
    Methods Enzymol; 2005; 402():423-43. PubMed ID: 16401518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerator mass spectrometry best practices for accuracy and precision in bioanalytical (14)C measurements.
    Vogel JS; Giacomo JA; Schulze-König T; Keck BD; Lohstroh P; Dueker S
    Bioanalysis; 2010 Mar; 2(3):455-68. PubMed ID: 21083255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the technique.
    Young G; Ellis W; Ayrton J; Hussey E; Adamkiewicz B
    Xenobiotica; 2001; 31(8-9):619-32. PubMed ID: 11569529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a 250 kV single-stage accelerator mass spectrometer with a 5 MV tandem accelerator mass spectrometer--fitness for purpose in bioanalysis.
    Young GC; Corless S; Felgate CC; Colthup PV
    Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4035-42. PubMed ID: 19009519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerator mass spectrometry at Arizona: geochronology of the climate record and connections with the ocean.
    Jull AJ; Burr GS; Beck JW; Donahue DJ; Biddulph D; Hatheway AL; Lange TE; McHargue LR
    J Environ Radioact; 2003; 69(1-2):3-19. PubMed ID: 12860086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerator mass spectrometry.
    Hellborg R; Skog G
    Mass Spectrom Rev; 2008; 27(5):398-427. PubMed ID: 18470926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective determination of the long-lived nuclide 41Ca in nuclear reactor bioshield concretes: comparison of liquid scintillation counting and accelerator mass spectrometry.
    Warwick PE; Croudace IW; Hillegonds DJ
    Anal Chem; 2009 Mar; 81(5):1901-6. PubMed ID: 19178149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdose study of 14C-acetaminophen with accelerator mass spectrometry to examine pharmacokinetics of parent drug and metabolites in healthy subjects.
    Tozuka Z; Kusuhara H; Nozawa K; Hamabe Y; Ikushima I; Ikeda T; Sugiyama Y
    Clin Pharmacol Ther; 2010 Dec; 88(6):824-30. PubMed ID: 21048707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meeting the MIST regulations: human metabolism in Phase I using AMS and a tiered bioanalytical approach.
    Lappin G; Seymour M; Gross G; Jørgensen M; Kall M; Kværnø L
    Bioanalysis; 2012 Feb; 4(4):407-16. PubMed ID: 22394141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-level occupational 14C contamination--results from a pilot study.
    Stenström K; Leide-Svegborn S; Mattsson S
    Radiat Prot Dosimetry; 2008; 130(3):337-42. PubMed ID: 18283056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroscience and accelerator mass spectrometry.
    Palmblad M; Buchholz BA; Hillegonds DJ; Vogel JS
    J Mass Spectrom; 2005 Feb; 40(2):154-9. PubMed ID: 15706618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of (14)C-accelerator MS in pharmaceutical development.
    Young GC; Seymour M
    Bioanalysis; 2015; 7(5):513-7. PubMed ID: 25826133
    [No Abstract]   [Full Text] [Related]  

  • 16. Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology.
    White IN; Brown K
    Trends Pharmacol Sci; 2004 Aug; 25(8):442-7. PubMed ID: 15276714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitating isotopic molecular labels with accelerator mass spectrometry.
    Vogel JS; Love AH
    Methods Enzymol; 2005; 402():402-22. PubMed ID: 16401517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry.
    Balani SK; Nagaraja NV; Qian MG; Costa AO; Daniels JS; Yang H; Shimoga PR; Wu JT; Gan LS; Lee FW; Miwa GT
    Drug Metab Dispos; 2006 Mar; 34(3):384-8. PubMed ID: 16326814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of radiocarbon-labelled tracer molecules in neural tissue using accelerator mass spectrometry.
    Hedges RE; Jiang ZX; Ramsey CB; Cowey A; Roberts JD; Somogyi P
    Nature; 1996 Oct; 383(6603):823-6. PubMed ID: 8893007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerator MS: its role as a frontline bioanalytical technique.
    Seymour MA
    Bioanalysis; 2011 Dec; 3(24):2817-23. PubMed ID: 22185281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.